RECRUITING

Testing a Gender-inclusive HIV Prevention Program

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.

Official Title

Harnessing the Power of Technology to Develop a Population-based HIV Prevention Program for Trans Girls

Quick Facts

Study Start:2024-09-01
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06586151

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. assigned male sex at birth and currently have a non-cisgender identity (e.g., transgender girl, non-binary, gender fluid, unsure);
  2. 2. aged 14-18 years and have not yet graduated high school;
  3. 3. English-speaking;
  4. 4. the sole user of a cell phone with an unlimited text messaging plan;
  5. 5. have access to the Internet to complete online surveys;
  6. 6. intend to have the same cell number for the next 6 months;
  7. 7. provide informed assent;
  8. 8. not have taken part in a previous #TranscendentHealth study activity or know someone who is in the study to increase the diversity of input from transgirls, and
  9. 9. agree to enroll over the phone with study staff.
  1. * None beyond not meeting inclusion criteria

Contacts and Locations

Study Contact

Michele Ybarra, PhD
CONTACT
8773026858
michele@innovativepublichealth.org

Study Locations (Sites)

Center for Innovative Public Health Research
San Clemente, California, 92672-6745
United States

Collaborators and Investigators

Sponsor: Center for Innovative Public Health Research

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-01
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2024-09-01
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • HIV
  • Adolescence
  • mHealth

Additional Relevant MeSH Terms

  • HIV Prevention